Prague, Czechia

Radek Spisek

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017-2020

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Radek Spisek: Innovator in Cancer Immunotherapy

Introduction

Radek Spisek is a prominent inventor based in Prague, Czech Republic. He has made significant contributions to the field of cancer immunotherapy, holding a total of 4 patents. His innovative work focuses on the cryopreservation of apoptotic cancer cells, which has the potential to revolutionize cancer treatment.

Latest Patents

One of Radek Spisek's latest patents involves a reliable method for preparing a potent vaccine for immunotherapy. This method includes the cryopreservation of a population of cells undergoing immunogenic cell death. The process utilizes these cells to activate dendritic cells, which are crucial for effective immunotherapy. Specifically, the method comprises cryopreserving cancer cells that are undergoing cell death, allowing for the preparation of a pharmaceutical composition aimed at combating cancer.

Career Highlights

Radek Spisek is currently associated with Sotio a.s., a company dedicated to advancing cancer treatment through innovative therapies. His work at Sotio a.s. has positioned him as a key player in the development of immunotherapeutic strategies.

Collaborations

Radek collaborates with talented individuals such as Jitka Fucikova and Lenka Koci. Their combined expertise contributes to the advancement of research and development in the field of cancer immunotherapy.

Conclusion

Radek Spisek's contributions to cancer immunotherapy through his innovative patents and collaborations highlight his role as a leading inventor in this critical area of medical research. His work continues to pave the way for new therapeutic approaches in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…